We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

120 hedge funds and large institutions have $168M invested in Rigel Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 121 → 120 (-1)

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

32% less capital invested

Capital invested by funds: $248M → $168M (-$79.7M)

Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
3.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
49
Reduced
30
Closed
12
Calls
$27K
Puts
–
Net Calls
+$27K
Net Calls Change
-$53K

Top Buyers

1
SCM
Sio Capital Management
New York
+$3.99M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.67M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.59M
4
DCM
DAFNA Capital Management
California
+$1.89M
5
PC
Paulson & Co
New York
+$1.16M

Top Sellers

1
BC
Broadfin Capital
New York
-$9.47M
2
Axa
Axa
France
-$5.86M
3
UBS AM
UBS AM
Illinois
-$4.12M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.42M
5
TC
TFS Capital
Pennsylvania
-$952K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
51
Acadian Asset Management
Massachusetts
$351K +$369K +14,947 +767%
NFA
52
Nationwide Fund Advisors
Ohio
$331K – – –
GPP
53
Great Point Partners
Connecticut
$328K +$389K +15,787 New
USAA
54
United Services Automobile Association
Texas
$289K +$10.4K +420 +3%
AG
55
Algert Global
California
$274K +$190K +7,693 +140%
TA
56
Teachers Advisors
New York
$268K – – –
CAM
57
ClariVest Asset Management
California
$267K +$42.9K +1,740 +16%
PAM
58
Panagora Asset Management
Massachusetts
$265K +$30.2K +1,223 +11%
PPA
59
Parametric Portfolio Associates
Washington
$262K -$9.2K -373 -3%
ARTA
60
A.R.T. Advisors
New York
$242K -$20.7K -840 -7%
AllianceBernstein
61
AllianceBernstein
Tennessee
$236K – – –
Morgan Stanley
62
Morgan Stanley
New York
$234K -$285K -11,546 -51%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$228K – – –
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$221K +$10.1K +410 +4%
AA
65
ALPS Advisors
Colorado
$207K -$42.1K -1,706 -15%
OC
66
Oppenheimer & Co
New York
$193K +$1.04K +42 +0.5%
Citigroup
67
Citigroup
New York
$174K +$112K +4,527 +117%
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$170K – – –
Goldman Sachs
69
Goldman Sachs
New York
$170K +$55.6K +2,254 +38%
ProShare Advisors
70
ProShare Advisors
Maryland
$158K -$20.2K -818 -10%
BG
71
BlackRock Group
United Kingdom
$158K – – –
UBS AM
72
UBS AM
Illinois
$156K -$4.12M -167,014 -96%
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$141K +$2K +81 +1%
CCMH
74
Cornerstone Capital Management Holdings
New York
$134K +$89.3K +3,620 +128%
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$131K +$3.8K +154 +2%
1 2
3
4 5

RIGL Hedge Fund Activity: Q1 2016 in Review

120 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q1 2016, worth a combined $168M — down 32% from $248M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RIGL and 11 opened new positions — a net loss of 1 holder — while 30 trimmed existing stakes and 49 added.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $3.99M. The largest seller was Broadfin Capital, exiting entirely with an estimated $9.47M sold.

  • 120 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $168M of Rigel Pharmaceuticals stock for Q1 2016, down 32% quarter-over-quarter.
  • 11 funds opened new Rigel Pharmaceuticals positions in Q1 2016 and 12 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q1 2016 was Sio Capital Management, an estimated $3.99M added.
  • The largest Rigel Pharmaceuticals seller in Q1 2016 was Broadfin Capital, an estimated $9.47M sold.

Based on aggregated 13F filings for Q1 2016.